T-cell receptor recognizing diphtheria toxoid-derived peptides (TCR-DT)

The CD4+ T-cell receptor (TCR) recognizing diphtheria toxoid-derived peptides is a specialized protein complex found on the surface of helper T-lymphocytes. It plays a critical role in the adaptive immune system by identifying processed fragments of the diphtheria toxin, which are presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (APCs) [PubMed: 15661903]. Upon binding, the TCR initiates a signaling cascade that activates the T-cell, leading to the secretion of cytokines and the stimulation of B-cells to produce neutralizing antibodies against the diphtheria toxin [PubMed: 25227750]. This interaction is the fundamental mechanism by which diphtheria vaccines, such as DTaP and Tdap, confer long-term immunity [PubMed: 19154951]. Understanding the specificity and diversity of these TCRs is essential for evaluating vaccine efficacy and developing next-generation immunotherapies [PubMed: 31064857]. While primarily beneficial, aberrant TCR activation can occasionally lead to hypersensitivity or localized inflammatory responses at the site of vaccination [PubMed: 10630152].

Other names

Diphtheria toxoid-specific T-cell receptorDT-specific TCRMHC class II-restricted T-cell receptorCD4+ T-cell receptor for diphtheria toxoid

The T-cell receptor (TCR) binds to specific diphtheria toxoid peptides presented by MHC class II molecules, triggering intracellular signaling cascades that lead to T-cell proliferation, cytokine secretion, and B-cell help for antitoxin antibody production.